Imperial College London Diabetes Centre holds the highly prestigious Joint Commission International (JCI) accreditation and certification for high standards of care at the Centre’s two locations in Abu Dhabi and Al Ain.
The JCI Gold Seal of Approval®, represents a symbol of quality that reflects an organisation’s commitment to providing safe and effective patient care and is highly regarded by the healthcare sector.
Imperial College London Diabetes Centre has been at the forefront of international accreditation in the country since it became the first healthcare provider worldwide in 2010 to receive both the JCI Clinical Care Program Certification (CCPC) for Diabetes Management and the JCI Accreditation for Ambulatory Care. At the same time, it also became the first facility in the Middle East and the third around the world to hold JCI’s highly-acclaimed CCPC specifically for the clinical management of diabetes. The Centres in Abu Dhabi and Al Ain were reaccredited in March 2016.
Imperial College London Diabetes Centre’s laboratories are also ISO 15189:2012 accredited and in full compliance with local licensing bodies, HAAD and Ministry of Health. The Centre's laboratories are also accredited by the College of American Pathologists (CAP).